ORGO
Organogenesis Holdings Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +7.8% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | +3 | 49.96M | $121.38M | +7 | −3 |
| Q1 2026 | 63 | -8 | 40.42M | $96.13M | +5 | −14 |
| Q4 2025 | 72 | +2 | 50.45M | $261.28M | +3 | — |
| Q3 2025 | 15 | -1 | 28.00M | $118.17M | — | −2 |
| Q2 2025 | 14 | -1 | 16.35M | $59.84M | — | −1 |
| Q1 2025 | 12 | +1 | 8.11M | $35.03M | +1 | — |
| Q4 2024 | 11 | 0 | 8.24M | $26.36M | — | — |
| Q3 2024 | 10 | 0 | 7.43M | $21.26M | — | — |
| Q2 2024 | 10 | — | 6.90M | $19.31M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | AQR Capital Management ✦ | 2.71M | +19.5% | $7.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | AQR Capital Management ✦ | 2.71M | +19.5% | $7.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 2.71M | +19.5% | $7.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 1.75M | -0.1% | $4.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.75M | -0.1% | $4.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 817.90K | +2.8% | $2.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 738.12K | -0.5% | $2.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 738.12K | -0.5% | $2.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Norges Bank ✦ (pasif) | 482.20K | 0.0% | $1.38M | 0.0% | Held | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 303.66K | +13.6% | $868,473 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 241.65K | +8.0% | $691,113 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 241.65K | +8.0% | $691,113 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 202.66K | +51.4% | $579,593 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 137.85K | -25.2% | $394,262 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 53.44K | +4.9% | $153,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 121 pemegang, 62.04M saham, $141.33M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.